{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:13:42Z","timestamp":1761743622148},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T00:00:00Z","timestamp":1334534400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0035363","type":"journal-article","created":{"date-parts":[[2012,4,17]],"date-time":"2012-04-17T13:26:06Z","timestamp":1334669166000},"page":"e35363","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":20,"title":["Performance of Survivin mRNA as a Biomarker for Bladder Cancer in the Prospective Study UroScreen"],"prefix":"10.1371","volume":"7","author":[{"given":"Georg","family":"Johnen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Gawrych","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heike","family":"Bontrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beate","family":"Pesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirk","family":"Taeger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S\u00e9verine","family":"Banek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias","family":"Kluckert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Wellh\u00e4u\u00dfer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friedhelm","family":"Eberle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Nasterlack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnulf","family":"Stenzl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Br\u00fcning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"and the UroScreen Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,4,16]]},"reference":[{"article-title":"Krebs in Deutschland 2005\/2006. H\u00e4ufigkeiten und Trends","year":"2010","author":"Robert Koch-Institut","key":"ref1"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"4096","DOI":"10.1002\/cncr.24463","article-title":"Key concerns about the current state of bladder cancer: a position paper from the Bladder Cancer Think Tank, the Bladder Cancer Advocacy Network, and the Society of Urologic Oncology.","volume":"115","author":"Y Lotan","year":"2009","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.2011.1142","article-title":"Association between smoking and risk of bladder cancer among men and women.","volume":"306","author":"ND Freedman","year":"2011","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1002\/cncr.22084","article-title":"Should we screen for bladder cancer in a high-risk population?: A cost per life-year saved analysis.","volume":"107","author":"Y Lotan","year":"2006","journal-title":"Cancer"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.urology.2005.08.065","article-title":"Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers.","volume":"66","author":"T Habuchi","year":"2005","journal-title":"Urology"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.urology.2005.08.064","article-title":"Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers.","volume":"66","author":"VB Lokeshwar","year":"2005","journal-title":"Urology"},{"key":"ref7","first-page":"1","article-title":"Molecular markers for bladder cancer screening, early diagnosis, and surveillance.","author":"BJ Schmitz-Dr\u00e4ger","year":"2012"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma.","volume":"3","author":"G Ambrosini","year":"1997","journal-title":"Nat Med"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc2293","article-title":"Survivin, cancer networks and pathway-directed drug discovery.","volume":"8","author":"DC Altieri","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/77929","article-title":"Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement.","volume":"7","author":"MA Verdecia","year":"2000","journal-title":"Nat Struct Biol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1097-2765(05)00020-1","article-title":"Crystal structure of human survivin reveals a bow tie-shaped dimer with two unusual alpha-helical extensions.","volume":"6","author":"L Chantalat","year":"2000","journal-title":"Mol Cell"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2007.07.045","article-title":"Structure of a Survivin-Borealin-INCENP core complex reveals how chromosomal passengers travel together.","volume":"131","author":"AA Jeyaprakash","year":"2007","journal-title":"Cell"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/bi0485171","article-title":"Solution structure of human survivin and its binding interface with Smac\/Diablo.","volume":"44","author":"C Sun","year":"2005","journal-title":"Biochemistry"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1126\/science.1189435","article-title":"Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis.","volume":"330","author":"F Wang","year":"2010","journal-title":"Science"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1126\/science.1189505","article-title":"Survivin reads phosphorylated histone H3 threonine 3 to activate the mitotic kinase Aurora B.","volume":"330","author":"AE Kelly","year":"2010","journal-title":"Science"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1126\/science.1194498","article-title":"Two histone marks establish the inner centromere and chromosome bi-orientation.","volume":"330","author":"Y Yamagishi","year":"2010","journal-title":"Science"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ccr.2009.11.021","article-title":"IAP regulation of metastasis.","volume":"17","author":"S Mehrotra","year":"2010","journal-title":"Cancer Cell"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"4349","DOI":"10.1073\/pnas.072586399","article-title":"A role for survivin in chemoresistance of endothelial cells mediated by VEGF.","volume":"99","author":"J Tran","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1182\/blood-2006-02-003749","article-title":"Dissecting the role of endothelial SURVIVIN DeltaEx3 in angiogenesis.","volume":"109","author":"H Caldas","year":"2007","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer.","volume":"100","author":"D Hanahan","year":"2000","journal-title":"Cell"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"7012","DOI":"10.1158\/1078-0432.CCR-08-2554","article-title":"Survivin as a prognostic marker for urothelial carcinoma of the bladder: a multicenter external validation study.","volume":"15","author":"SF Shariat","year":"2009","journal-title":"Clin Cancer Res"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1136\/gut.46.5.645","article-title":"Expression of the antiapoptosis gene, survivin, predicts death from recurrent colorectal carcinoma.","volume":"46","author":"AI Sarela","year":"2000","journal-title":"Gut"},{"key":"ref23","first-page":"1921","article-title":"Prognostic significance of survivin expression in diffuse large B-cell lymphomas.","volume":"96","author":"C Adida","year":"2000","journal-title":"Blood"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/00129039-200403000-00009","article-title":"Prognostic significance of anti-apoptosis proteins survivin and bcl-2 in non-small cell lung carcinomas: a clinicopathologic study of 102 cases.","volume":"12","author":"L Kren","year":"2004","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3835(02)00190-8","article-title":"Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma.","volume":"184","author":"N Takai","year":"2002","journal-title":"Cancer letters"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1471-4914(01)02243-2","article-title":"The molecular basis and potential role of survivin in cancer diagnosis and therapy.","volume":"7","author":"DC Altieri","year":"2001","journal-title":"Trends Mol Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM199908053410614","article-title":"Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer.","volume":"341","author":"HS Swana","year":"1999","journal-title":"N Engl J Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1001\/jama.285.3.324","article-title":"Urine detection of survivin and diagnosis of bladder cancer.","volume":"285","author":"SD Smith","year":"2001","journal-title":"JAMA"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.ju.0000107826.78479.90","article-title":"Urine detection of survivin is a sensitive marker for the noninvasive diagnosis of bladder cancer.","volume":"171","author":"SF Shariat","year":"2004","journal-title":"J Urol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00432-004-0561-z","article-title":"The expression and significance of survivin mRNA in urinary bladder carcinomas.","volume":"130","author":"H Wang","year":"2004","journal-title":"J Cancer Res Clin Oncol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/ijc.21000","article-title":"Quantitative analysis of survivin mRNA expression in urine and tumor tissue of bladder cancer patients and its potential relevance for disease detection and prognosis.","volume":"116","author":"S Weikert","year":"2005","journal-title":"Int J Cancer"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1016\/S0022-5347(06)00254-0","article-title":"Evaluation of survivin reverse transcriptase-polymerase chain reaction for noninvasive detection of bladder cancer.","volume":"175","author":"O Moussa","year":"2006","journal-title":"J Urol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000099033","article-title":"Detection of newly diagnosed bladder cancer, bladder cancer recurrence and bladder cancer in patients with hematuria using quantitative RT-PCR of urinary survivin.","volume":"28","author":"DM Kenney","year":"2007","journal-title":"Tumour Biol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00345-010-0538-2","article-title":"Clinical experience with survivin as a biomarker for urothelial bladder cancer.","volume":"28","author":"M Horstmann","year":"2010","journal-title":"World J Urol"},{"key":"ref35","first-page":"128","article-title":"Bladder cancer screening with urine-based tumour markers - occupational medical experience.","volume":"42","author":"M Nasterlack","year":"2011","journal-title":"Aktuelle Urol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1464-410X.2010.09971.x","article-title":"The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.","volume":"108","author":"B Pesch","year":"2011","journal-title":"BJU Int"},{"key":"ref37","article-title":"NMP22 - prospective evaluation in a population at risk for bladder cancer: results from the UroScreen-Study.","author":"S Huber","year":"2012","journal-title":"BJU Int"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.urolonc.2009.11.004","article-title":"Considerations on implementing diagnostic markers into clinical decision making in bladder cancer.","volume":"28","author":"Y Lotan","year":"2010","journal-title":"Urol Oncol"},{"key":"ref39","first-page":"17","article-title":"Harnblasenkrebs in einem Risikokollektiv: Klinische und epidemiologische Aspekte.","volume":"12","author":"M Nasterlack","year":"2001","journal-title":"Symp Med"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1002\/1097-0142(20011201)92:11<2820::AID-CNCR10092>3.0.CO;2-I","article-title":"Utility of serial urinary tumor markers to individualize intervals between cystoscopies in the monitoring of patients with bladder carcinoma.","volume":"92","author":"M Sanchez-Carbayo","year":"2001","journal-title":"Cancer"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1200\/JCO.2009.25.6065","article-title":"Sources of bias in specimens for research about molecular markers for cancer.","volume":"28","author":"DF Ransohoff","year":"2010","journal-title":"J Clin Oncol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4137\/BMI.S5522","article-title":"Assessment of mRNA and microRNA Stabilization in Peripheral Human Blood for Multicenter Studies and Biobanks.","volume":"5","author":"DG Weber","year":"2010","journal-title":"Biomark Insights"},{"article-title":"Urinzytologie. Praxis und Atlas","year":"1991","author":"P Rathert","key":"ref43"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0035363","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T02:50:44Z","timestamp":1540349444000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0035363"}},"subtitle":[],"editor":[{"given":"Olga Y.","family":"Gorlova","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,4,16]]},"references-count":43,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2012,4,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0035363","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2012,4,16]]}}}